EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 21-Oct-2026 14:16 ET (21-Oct-2026 18:16 GMT/UTC)

10-Sep-2026

$3.3 million NIH grant funds Upstate research into new immunotherapy for leukemia

State University of New York Upstate Medical University
Grant and Award Announcement

Upstate immunologist Mobin Karimi, MD/PhD, has been awarded a $3.3 million grant to explore a new type of immunotherapy to treat acute myeloid leukemia.

The grant comes from the National Cancer Institute of the National Institutes of Health.

10-Sep-2026

Scientists uncover how cells surrounding primary liver tumors may help fuel cancer

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

UCLA researchers have identified a pathway in liver cells that may explain how statins could help prevent or slow the development of liver cancer associated with fatty liver disease.

Journal: Hepatology Communications

10-Sep-2026

Rare Coombs-negative hemolytic anemia reported following pembrolizumab treatment

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — September 10, 2026 — A new case report was published in Volume 13 of Oncoscience on August 12, 2026, titled “Pembrolizumab-associated Coombs-negative autoimmune hemolytic anemia in metastatic lung adenocarcinoma with concurrent thromboembolism and bacteremia: A case report with literature review.”

Journal: Oncoscience

10-Sep-2026

AI-enabled analysis of pathology slides may help assess risk of pancreatic cancer recurrence

Mayo Clinic
Peer-Reviewed Publication

Mayo Clinic researchers have found that artificial intelligence (AI)-enabled spatial analysis can identify patterns in routine pathology slides that may help clinicians identify which patients with pancreatic cancer are at greater risk of recurrence after treatment and surgery.

Journal: Clinical Cancer Research
Funder: Gerstner Family Foundation Career Development Award, Grand Forks Career Development Award, Mayo Clinic Center for Clinical and Translational Science, ARPA-H ADAPT

10-Sep-2026

Pembrolizumab plus chemotherapy for cervical cancer

JAMA Network
Peer-Reviewed Publication

About the Study: In this exploratory analysis of the KEYNOTE-826 randomized clinical trial, the 5-year data confirm the durability of benefit and reinforce pembrolizumab plus chemotherapy (with or without bevacizumab) as a first-line standard-of-care option for recurrent and metastatic cervical cancer.

Journal: JAMA Oncology

10-Sep-2026

Protein linked to cell death may also drive liver cancer

University of Oklahoma
Peer-Reviewed Publication

New research from the University of Oklahoma identifies a protein in liver cells that appears to help drive the development of liver cancer associated with obesity-related fatty liver disease. The finding, published in Hepatology, points to the protein as a potential new therapeutic target for liver cancer.

Journal: Hepatology

10-Sep-2026

New NCCN survey highlights persistent cancer medication shortages across United States

National Comprehensive Cancer Network
Reports and Proceedings

NCCN is publishing updated data on generic cancer medication shortages in the United States. 100% of responding cancer centers are experiencing a shortage for at least one anti-cancer agent; with more than 20% of centers currently in shortage for five or more different medications.

10-Sep-2026

Aging brain biology may help shape brain tumor progression

Science Exploration Press
Peer-Reviewed Publication

Brain tumors develop within an organ that changes substantially with age. A new review in Ageing and Cancer Research & Treatment examines evidence that the aging brain microenvironment may influence brain tumor progression, treatment resistance, and cognitive outcomes.

Journal: Ageing and Cancer Research & Treatment
Funder: National Natural Science Foundation of China, National Natural Science Foundation of China, Shanghai Municipal Health Commission

10-Sep-2026

Child cancer groups call for concerted action

Cold Spring Harbor Laboratory
Peer-Reviewed Publication

Scientists, clinicians, and patient advocates from across the pediatric sarcoma community called for bridging cancer drug discovery and treatment through a unified clinical infrastructure. After meeting at Cold Spring Harbor Laboratory’s Banbury Center, the group outlined future research priorities and healthcare opportunities in an article for the journal Genes & Development.

Journal: Genes & Development
Funder: The Mary Ruchalski Foundation, Christina Renna Foundation, Friends of T.J. Foundation, The Michelle Paternoster Foundation, Williams Echo, Maddie's Promise, Wings for Ewing Sarcoma, Scarola Stark Family, Dana-Farber Cancer Institute, Novartis, Kronos Bio, Boehringer Ingelheim, Treeline Biosciences

10-Sep-2026

AI-assisted imaging tool for breast cancer could tailor screening for women according to individual risk

NYU Langone Health / NYU Grossman School of Medicine
Peer-Reviewed Publication

An artificial intelligence model that analyzes women’s past and recent annual 3D mammograms is more effective at predicting five-year risk of developing breast cancer than a tool that uses only the most recent, single 3D mammogram, as well as an AI model that analyzes 2D mammograms, a new study shows.

Journal: American Journal of Roentgenology